Clinical Trial Update: Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update involving postoperative IMRT with capecitabine for advanced gastric cancer; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN